Diffusion Basis Spectrum Imaging of White Matter in Schizophrenia and Bipolar Disorder

doi:10.21203/rs.3.rs-4940831/v1

Download PDF

Research Article

Diffusion Basis Spectrum Imaging of White Matter in Schizophrenia and Bipolar Disorder

https://doi.org/10.21203/rs.3.rs-4940831/v1

This work is licensed under a CC BY 4.0 License

You are reading this latest preprint version

Background:

Multiple studies point to the role of neuroinflammation in the pathophysiology of schizophrenia (SCZ), however, there have been few in vivo tools for imaging brain inflammation. Diffusion basis spectrum imaging (DBSI) is an advanced diffusion-based MRI method developed to quantitatively assess microstructural alternations relating to neuroinflammation, axonal fiber, and other white matter (WM) pathologies.

Methods:

We acquired one-hour-long high-directional diffusion MRI data from young control (CON, n =27), schizophrenia (SCZ, n =21), and bipolar disorder (BPD, n =21) participants aged 18-30. We applied Tract-based Spatial Statistics (TBSS) to allow whole-brain WM analyses and compare DBSI-derived isotropic and anisotropic diffusion measures between groups. Clinical relationships of DBSI metrics with clinical symptoms were assessed across SCZ and control participants.

Results:

In SCZ participants, we found a generalized increase in DBSI-derived cellularity (a putative marker of neuroinflammation), a decrease in restricted fiber fraction (a putative marker of apparent axonal density), and an increase in extra-axonal water (a putative marker of vasogenic edema) across several WM tracts. There were only minimal WM abnormalities noted in BPD, mainly in regions of the corpus callosum (increase in DTI-derived RD and extra-axonal water). DBSI metrics showed significant partial correlations with psychosis and mood symptoms across groups.

Conclusion:

Ourfindings suggest that SCZ involves generalized white matter neuroinflammation, decreased fiber density, and demyelination, which is not seen in bipolar disorder. Larger studies are needed to identify medication-related effects. DBSI metrics could help identify high-risk groups requiring early interventions to prevent the onset of psychosis and improve outcomes.

Schizophrenia

bipolar disorder

neuroinflammation

diffusion

dbsi

tbss

brain

connectivity

fiber density

Schizophrenia (SCZ) is a chronically disabling psychiatric disorder afflicting 0.5-1% of the population. The pathophysiology of the disorder is unclear and complicated by the heterogeneity of clinical, postmortem, and imaging findings. However, SCZ has been associated with reductions in cortical thickness, as well as cortical surface area, primarily in frontal and temporal regions.(Godwin et al., 2018) Explaining the underlying causes of cortical changes, neuropathological studies have shown increased neuronal packing density in the cortex, due to both decreased neuropil and soma size.(Jaaro-Peled et al., 2010) Dendrites are shorter and less branched and spine density is also lower in those with SCZ compared to healthy individuals,(BYNE et al., 2006) which is thought to underlie the neuronal connectivity abnormalities reported in SCZ patients.(Black et al., 2004) Additionally, fewer oligodendrocytes in various brain regions have been found in SCZ further contributing to neuronal dysconnectivity in the disorder, and white matter deficits found in brain imaging studies.(Jaaro-Peled et al., 2010)

White matter volumes are often reduced in SCZ patients, but generally to a lesser extent than cortical volumes.(Kubicki et al., 2005) Diffusion imaging studies in SCZ typically report lower fractional anisotropy (FA) in one or more white matter tracts, however, the specificity of significant abnormalities has been heterogeneous across studies.(Arnedo et al., 2015; Mamah et al., 2010, 2019) The large, multi-site ENIGMA study involving 4322 individuals found widespread FA reduction in SCZ, with the anterior corona radiata (d = 0.40) and corpus callosum (d = 0.39) showing the greatest effects.(Kelly et al., 2018) Myelin deficits are thought to play a major role in observed diffusion imaging abnormalities, considering that increased radial diffusivity is usually seen in SCZ,(Levitt et al., 2012) and dysregulation of myelin-associated gene expression, reductions in oligodendrocyte numbers, and marked abnormalities in the ultrastructure of myelin sheaths have also been reported.(Alba-Ferrara & de Erausquin, 2013)

Multiple lines of evidence have attributed neuroinflammation to SCZ,(Marques et al., 2019) which appears to precede the onset of illness.(Khoury & Nasrallah, 2018) Peripheral inflammatory markers (e.g., IL-1β, IL-6, and TNF-α) are often seen in individuals with SCZ,(Bishop et al., 2022; Goldsmith et al., 2016) although diagnostic specificity remains to be established and is also seen in other psychiatric disorders.(Bishop et al., 2022) Robust evidence has also been reported for increased proinflammatory cytokines in the prodromal period,(Corsi-Zuelli & Deakin, 2021) and prenatal exposure to specific infections has been associated with future SCZ development.(Brown & Derkits, 2010) Furthermore, results from genetic studies support the role of immune dysregulation in the pathophysiology of SCZ – a large multi-site study found that the most significantly associated SCZ genome-wide association study (GWAS) locus lies within the major histocompatibility complex (MHC) locus on chromosome 6, which contains genes that function in the acquired immune system.(Ruzzo & Geschwind, 2016) Finally, positron emission tomography (PET) studies done in SCZ patients, using a variety of tracers, most commonly targeting the 18 kDa translocator protein, TSPO, have shown increased binding in the disorder.(Marques et al., 2019) While PET studies can measure neuroinflammatory proteins at low concentrations, obstacles to reliable measurement remain, such as high nonspecific binding and sensitivity to a genetic polymorphism that affects the binding affinity of early TSPO radioligands.(Narayanaswami et al., 2018) Other promising neuroinflammation-targeted ligands are currently in development.(Narayanaswami et al., 2018) Outside of PET, few non-invasive alternatives for investigating neuroinflammation in the brain have been proposed.(Quarantelli, 2015) In contrast to PET, such methods could facilitate longitudinal investigations, particularly in younger populations, and potentially have future clinical implications in monitoring treatment effects.

Diffusion Basis Spectrum Imaging (DBSI) is a novel multi-parametric diffusion imaging post-processing methodology that models the diffusion-weighted MRI signals as a linear combination of multiple tensors describing both the discrete anisotropic content (axonal fibers) and an isotropic diffusion spectrum component encompassing the full range of diffusivities.(Y. Wang et al., 2011, 2015) DBSI acquires water diffusion signals for each imaging voxel and then uses a pattern-matching algorithm to find the minimal number of dictionary entries that best represent the acquired water diffusion signals and their relative proportions. Each identified dictionary entry represents one type of microstructure in the image voxel.(Y. Wang et al., 2011, 2015) This modeling was developed to quantify intra- and extracellular water permitting the discrimination of vasogenic edema, increased cellularity, axonal injury/loss, and demyelination (see Fig. 1).(Y. Wang et al., 2011, 2015) Previous studies using DBSI have been done in Alzheimer’s disease where it showed increased cellular diffusivity in both preclinical and early symptomatic phases of Alzheimer’s disease consistent with white matter inflammation,(Q. Wang et al., 2019; Wu et al., 2022) despite traditional diffusion imaging abnormalities only identified in the symptomatic phase.(Q. Wang et al., 2019) DBSI has also been used in multiple sclerosis,(Cross & Song, 2017) cervical spondylotic myelopathy,(Zhang et al., 2022) obesity,(Samara et al., 2020) and HIV,(Strain et al., 2017) but has not been used to investigate individuals with SCZ or psychosis.

Our current study investigated the brains of schizophrenia participants using the DBSI methodology. We hypothesized that due to the presumed psychopathology underlying SCZ, primary abnormalities found with this method would involve increased cellular diffusion fraction across multiple white matter tracts compared to healthy controls. In the study, we also included individuals with bipolar disorder, as an additional comparison group to establish specificity of findings. While diffusion imaging abnormalities have often been found in bipolar disorder, these are generally less extensive and severe than those seen in schizophrenia.(Nortje et al., 2013) We hypothesize that similarly, cellular diffusion fraction in BPD will be increased compared to the control group but substantially less than in SCZ participants.

Subjects

Imaging data were acquired from three participant groups, aged 18 to 30-year-old recruited through community advertisements and volunteer databases: 27 healthy young control (CON), 21 schizophrenia (SCZ), and 21 bipolar disorder (BPD). These participants were diagnosed on the basis of a trained research assistant who used the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-IV).(First et al., 1996) CON subjects were required to have no lifetime history of psychotic or mood disorders. BPD participant patients were required to meet DSM-IV criteria for Bipolar I Disorder. To minimize clinical heterogeneity within the BPD group, only participants with a history of euphoric mania (versus mania characterized by primarily irritable mood) were included in the study. Written informed consent was obtained prior to participation, and all study protocols were approved by the Institutional Review Board at the Washington University School of Medicine in St. Louis, MO.

All participants were excluded if they: (a) met DSM-IV criteria for substance dependence or severe/moderate abuse during the prior 3 months; (b) had a clinically unstable or severe general medical disorder; or (c) had a history of head injury with documented neurological sequelae or loss of consciousness.

Behavioral assessments

Recent symptoms (i.e., in the prior two weeks) were assessed using the Scale for the Assessment of Negative Symptoms (SANS), and the Scale for the Assessment of Positive Symptoms (SAPS).(Andreasen, 1990) Chronic symptoms (i.e., prior year) were assessed using the Washington Early Recognition Center Affectivity and Psychosis (WERCAP) Screen, both affective (a-WERCAP) and psychosis (p-WERCAP) components.(Mamah et al., 2014, 2021, 2022)

Image acquisition

Structural T1w MRI images were acquired on a 3T Siemens Prisma with a 32 channel head coil using a 3D MPRAGE sequence(Mugler & Brookeman, 1990) (0.8 mm isotropic voxels, TR/TI = 2400/1000 ms, TE = 2.2 ms, flip angle = 8°, FOV = 256 ×240×166 mm, matrix size = 320 ×300, 208 sagittal slices, in-plane (iPAT) acceleration factor of 2). T2w volumes were also acquired at the same spatial resolution using the variable-flip-angle turbo-spin-echo 3D SPACE sequence(Mugler et al., 2000) (TR/TE = 3200/564 ms; same FOV, matrix and in-plane acceleration). The diffusion MRI (dMRI) scans used the multi-band (MB) sequences from the Center for Magnetic Resonance Research, with 1.25 isotropic voxels, TR = 5000 ms, TE = 104 ms, 6/8 partial Fourier, and MB factor = 4. A full dMRI session included 6 runs (each approximately 8.5 min), representing 3 different gradient tables, with each table acquired once with anterior-to-posterior and posterior-to-anterior phase encoding polarities, respectively. Each gradient table includes approximately 90 diffusion weighting directions plus 6 b = 0 acquisitions interspersed throughout each run. Diffusion weighting consisted of 3 shells of b = 1000, 2000, and 3000 s/mm² interspersed with an approximately equal number of acquisitions on each shell within each run.

Image preprocessing

The diffusion data were preprocessed using the “DiffusionPreprocessing” stream of the HCPpipelines (v4.3.0),(Glasser et al., 2013, 2016) using the QuNex container (v0.91.11). This pipeline includes intensity normalization, susceptibility distortion correction (via FSL’s ‘topup’),(Andersson et al., 2003) and correction for eddy current distortions and motion via FSL’s ‘eddy’ tool.(Andersson & Sotiropoulos, 2016) We used the advanced ‘eddy’ features of outlier replacement,(Andersson et al., 2016) slice-to-volume motion correction,(Andersson et al., 2017) and correction for susceptibility-by-movement interactions.(Andersson et al., 2018) The b-vectors were rotated to account for motion.(Sotiropoulos et al., 2013) Finally, the dMRI data was corrected for gradient nonlinearity distortion as part of resampling to the subject’s native T1w space from the HCP structural pipeline output (while maintaining the same 1.25 mm spatial resolution of the dMRI data). Following that preprocessing, two different diffusion models were implemented 1) diffusion tensor estimation using conventional FSL’s ‘DTI’ toolbox 2) modelled diffusion signal using DBSI and derived parameters such as cellular diffusion fraction, extra-axonal water, axonal fiber fraction, fiber axial, and fiber radial diffusivities. To perform voxel-wise analysis of all white matter tracts, Tract-based spatial statistics (TBSS) was used.(Smith et al., 2006) DTI-derived FA images were calculated and projected onto the mean FA skeleton, which represents center of white matter tracts, and thresholded at 0.2. After pre-alignment and skeletonization stage, the resulting 4D data was used to perform voxel-wise statistics.

DBSI

Diffusion data were modeled using the novel DBSI method. In DBSI, each of the potential pathological components, including inflammatory cell components, extra-cellular water/vasogenic edema, axonal injury/loss, and demyelination, is modelled within each voxel by a dedicated diffusion tensor. DBSI framework, as shown in Eq. (1), considers diffusion-weighted MRI data as a linear combination of multiple anisotropic (crossing myelinated and unmyelinated axons of varied direction; the first term) and a spectrum of isotropic (cells, sub-cellular structure, and edematous water; the second term)(Y. Wang et al., 2011) diffusion tensors.

$$\:{\varvec{S}}_{\varvec{k}}=\sum\:_{i=1}^{{N}_{Aniso}}{f}_{i}{e}^{-\left|\overrightarrow{{b}_{k}}\right|\bullet\:{\lambda\:}_{\perp\:\_i}}{e}^{-\left|\overrightarrow{{b}_{k}}\right|\bullet\:({\lambda\:}_{\parallel\:\_i}-\:{\lambda\:}_{\perp\:\_i})\bullet\:{cos}^{2}{\psi\:}_{ik}}+\:\underset{a}{\overset{b}{\int\:}}f\left(D\right){e}^{-\left|\overrightarrow{{b}_{k}}\right|D}dD\:(k=\text{1,2},\dots\:,K)$$

The quantities $\:{\varvec{S}}_{\varvec{k}}$ and $\:\left|\overrightarrow{{\varvec{b}}_{\varvec{k}}}\right|$ are the signal and b-value of the k^th diffusion gradient, $\:{\varvec{N}}_{\varvec{A}\varvec{n}\varvec{i}\varvec{s}\varvec{o}}$ is the number of anisotropic tensors (fiber tracts), $\:{\varvec{\psi\:}}_{\varvec{i}\varvec{k}}$ is the angle between the k^th diffusion gradient and the principal direction of the i^th anisotropic tensor, $\:{\varvec{\lambda\:}}_{\parallel\:\_\varvec{i}}$ and $\:{\varvec{\lambda\:}}_{\perp\:\_\varvec{i}}$ are the axial and radial diffusivities of the i^th anisotropic tensor, f_i is the signal intensity fraction for the i^th anisotropic tensor, and a and b are the low and high diffusivity limits for the isotropic diffusion spectrum f(D). In this study, the sum of f_i is defined as the fiber fraction to reflect the total white matter axonal fiber density. The summation of the anisotropic diffusion component with radial diffusivity bigger than 0.1 (⋅10^− 3 mm²/s) is defined as the extra-axonal water fraction to reflect the extra-axonal water edema in WM. The summation of the isotropic diffusion components with apparent diffusion coefficient between 0 and 0.3 (⋅10^− 3 mm²/s) is defined as the cellular diffusion fraction to reflect the total cellularity in WM.

Statistical analysis

Statistical analysis was performed using Kruskal-Wallis rank sum test for age and body mass index (BMI), and Pearson’s χ² test for gender. These statistical analyses were performed with the software package R, Version 4.3.1 (https://www.r-project.org/).

To perform voxel-wise group comparisons, a permutation based nonparametric statistical test was performed using “randomise” ࣧ a part of FSL.(Winkler et al., 2014) Two sample non-parametric t-tests were performed between CON, BPD, and SCZ groups. The mean FA skeleton was used as mask and number of permutations were set to 5000. The significance threshold for group differences was set at p < 0.05. The statistical significance maps were corrected for multiple comparisons using threshold free cluster enhancement (TFCE) option in “randomise”. Similarly, group comparisons of DBSI metrics were performed.

For each DBSI measure, voxels with statistically significant difference (p < 0.05 after FWER correction) resulting from group wise comparisons 1) control vs schizophrenia, and 2) control vs bipolar disorder were added together, and binary mask was created. DBSI measures were summarized for each subject using corresponding mask. Finally, Pearson’s correlation was performed between DBSI measures (only with statistically significant group difference in randomized test) and clinical scores with the software package R. As age and gender were not statistically different across groups, we did not control for it in above analysis.

Demographic and clinical profiles:

Table 1 shows demographic and clinical information across the participant groups. Mean age was similar across the three participant groups. The BPD group had substantially more females than males, while sex was more balanced in SCZ and CON.

Voxel-wise analysis of DTI-derived fractional anisotropy, radial diffusivity, and axial diffusivity

Table 2 shows white matter tracts where DBSI and DTI measures are significantly different in schizophrenia and bipolar disorder groups compared to control group.

As shown in Fig. 2A, we observed low fractional anisotropy (FA) in SCZ compared to controls. The reduced FA was bilaterally distributed over anterior thalamic radiation, corticospinal tract, cingulum (both cingulate gyrus and hippocampus), forceps major, forceps minor, inferior fronto-occipital fasciculus, inferior longitudinal fasciculus, and superior longitudinal fasciculus. In contrast to findings in SCZ, the FA in BPD participants were minimal and were only observed unilaterally over anterior thalamic radiation, inferior fronto-occipital fasciculus, uncinate fasciculus, bilaterally in cingulum (cingulate gyrus) and forceps minor (Fig. 2B).

No significant axial diffusivity (AD) abnormalities were seen in either SCZ (Fig. 2C) or BPD (Fig. 2D) participants. SCZ subjects however had significantly higher radial diffusivity (RD) than controls in similar regions where decreased FA was observed, as shown in Fig. 2E. No significant abnormalities in RD were observed in BPD (Fig. 2F).

Voxel-wise analysis of cellular diffusion fraction

Relative to controls, SCZ had significantly increased cellular diffusion fraction — a putative marker of white matter inflammation (Fig. 3A), bilaterally spread over anterior thalamic radiation, corticospinal tract, cingulum bundle, forceps major, forceps minor, inferior fronto-occipital fasciculus, uncinate fasciculus, and superior longitudinal fasciculus.

No significant alterations in cellular diffusion fraction were observed in BPD after FWER correction (Fig. 3B).

Voxel-wise analysis of axonal fiber fraction

Compared to controls, SCZ had statistically decreased fiber fraction (Fig. 4A) bilaterally in anterior thalamic radiation, corticospinal tract, cingulum bundle, forceps major, forceps minor, inferior fronto-occipital fasciculus, uncinate fasciculus, and temporal region of superior longitudinal fasciculus.

Compared to controls, changes in the axonal fiber fraction were not statistically significant in BPD (Fig. 4B).

Voxel-wise analysis of extra-axonal water fraction

As shown in Fig. 5, compared to controls, SCZ and BPD had statistically increased extra-axonal water fraction (Panel A and Panel B respectively). In both SCZ and BPD, increased extra-axonal water fraction was present bilaterally over anterior thalamic radiation, corticospinal tract, cingulum bundle, forceps major, forceps minor, inferior fronto-occipital fasciculus, inferior longitudinal fasciculus, uncinate fasciculus, and superior longitudinal fasciculus.

Group comparison between SCZ and BPD did not reveal significant differences in the extra-axonal water fraction.

Voxel-wise analysis of DBSI-derived fiber axial and fiber radial diffusivity

Compared to controls, fiber axial diffusivity changes in SCZ (Fig. 6A), and BPD (Fig. 6B) did not survive the significance threshold after FWER correction.

Relative to controls, SCZ (Fig. 6C) had significantly increased fiber radial diffusivity, spread bilaterally over anterior thalamic radiation, corticospinal tract, cingulum bundle, forceps major, forceps minor, inferior fronto-occipital fasciculus, inferior longitudinal fasciculus, uncinate fasciculus, and superior longitudinal fasciculus. In BPD (Fig. 6D), increased fiber radial diffusivity was observed bilaterally over anterior thalamic radiation, corticospinal tract, cingulum bundle, forceps major, forceps minor, inferior fronto-occipital fasciculus, superior longitudinal fasciculus, unilaterally in right inferior longitudinal fasciculus and left uncinate fasciculus.

Correlation analysis between WERCAP symptom score and DBSI measures

Across healthy control and SCZ, a correlation of psychotic symptom scores against DBSI measures partialled for diagnosis showed significant effects (r > 0.55; p < 0.0001) for cellular diffusion fraction (Fig. 7A), fiber radial diffusivity (Fig. 7B), fiber fraction (Fig. 7C) and extra-axonal water fraction (Fig. 7D). The relationship between psychotic symptoms and DBSI metrics separately in SCZ and control participants did not meet statistical significance.

Similar findings were observed for the relationship between mood symptom scores and DBSI measures (Figs. 8A-D), though the relationship was weaker (r > 0.28; p < 0.05).

Our study expands the novel neuroimaging, diffusion basis spectrum imaging (DBSI), for the first time to the study of individuals with schizophrenia and bipolar disorder. DBSI is particularly promising in the study of those with psychiatric disorders, which generally do not have validated biomarkers with clinical utility. This method has been shown to distinguish various pathophysiologic changes of brain white matter in vivo in postmortem studies of central nervous system disorders.(Chiang et al., 2014)

The commonly used diffusion imaging metrics DTI-derived FA, RD and AD have been valuable in understanding brain microstructural abnormality in disease. However, establishing underlying when these metrics are abnormal is complicated by the fact that different pathologies can contribute to it. For example, while high RD is suggested to be largely related to axonal demyelination, other factors like edema and cellularity can confound symptoms. By delineating individual white matter components, DBSI-derived RD and AD are posited to minimize confounding effects, compared to DTI-derived metrics. Our study found a generalized bilateral increase in white matter RD in schizophrenia, without associated abnormality in AD. This suggests that demyelination and not axonal degeneration is likely the underlying microstructural pathology.(Baijot et al., 2022) A minimally elevated RD was also seen in BPD participants but only with DBSI, not with conventional DTI. Demyelination of white matter tracts is consistent with previous studies of schizophrenia. Postmortem samples have shown oligodendrocytes have been found to show consistent signs of dystrophia, apoptosis and/or necrosis, and their numerical density have been significantly reduced in schizophrenia.(Vostrikov & Uranova, 2020) Schizophrenia brain samples have also been characterized by downregulation of myelin-specific structural proteins and a reduction in mRNA levels of oligodendroglial lineage transcription factors, such as OLIG1, OLIG2 and SOX10.(Tkachev et al., 2003) Myelin-related abnormalities in schizophrenia would lead to disconnection of neural networks by impairing the saltatory conduction and information conduction between neurons.(Roussos & Haroutunian, 2014) Findings of high RD in schizophrenia appear to be disorder-specific, as similar changes were seen to a milder degree, consistent with fewer white matter abnormalities found in other studies.(Mamah et al., 2024)

A notable finding in our study was an elevated cellular diffusion fraction across multiple white matter regions exclusively in schizophrenia subjects. The DBSI metric generally correlates with elevated inflammatory cells and is seen in brain conditions with inflammatory underpinnings, such as multiple sclerosis,(Y. Wang et al., 2011) HIV infection,(Strain et al., 2017) and autoimmune encephalitis in mice.(X. Wang et al., 2014) There has been increasing evidence for an inflammatory signature in the brain in schizophrenia, including overexpression of pro-inflammatory cytokines,(Fillman et al., 2014) changes to the blood-brain barrier with macrophage infiltration(Cai et al., 2020) and possible microglia activation.(Howes & McCutcheon, 2017) Schizophrenia has also been associated with elevated peripheral inflammatory markers,(Bishop et al., 2022; Goldsmith et al., 2016) binding of pro-inflammatory PET tracers,(Marques et al., 2019) and genetic risk factors of immune dysregulation.(Ruzzo & Geschwind, 2016) Inflammatory markers have been found to precede the onset of illness(Corsi-Zuelli & Deakin, 2021; Khoury & Nasrallah, 2018) suggesting a progressive pathological process leading to an onset of schizophrenia. The absence of cellular diffusion fraction abnormalities in our bipolar disorder population suggests the specificity of this DBSI marker to schizophrenia. Although not clear from our results, it is worth speculating whether increased cellular diffusion fraction is confounded by increased density of interstitial white matter neurons in schizophrenia,(Yang et al., 2011) reflecting a deficiency in interneuron migration from white matter to cortex during development. Migration of these subplate neurons has been associated with environmental insults including maternal infection in early life and cannabis use during childhood and adolescence.(Duchatel et al., 2019)

Along with increased cellular diffusion fraction and decreased fiber fraction, we also found elevated extra-axonal water fraction, a marker of extra-axonal water edema, across multiple white matter tracts in schizophrenia participants. Taken together, these findings suggest that in our schizophrenia patients, there exists a pattern of inflammatory demyelination of low-density fiber tracts, with associated extra-axonal water edema. In bipolar disorder, microstructural changes suggested by DBSI results were milder degrees of demyelination and extra-axonal water edema only. Our findings also suggest that increased cellularity and decreased fiber density were specific to schizophrenia participants and may thus represent a disorder-specific biomarker representing a more extensive dysconnectivity syndrome. More importantly, it suggests that schizophrenia involves aberrant neurodevelopment of white matter tracts.

There are some limitations to our study. Due to the relatively small sample size, we did not control for potential confounders such as medications and substance use which are more common in those with severe psychiatric illnesses than in healthy controls. Antipsychotic medications for example have been associated with reductions in white matter FA(Q. Wang et al., 2013) and increases in white matter volume.(Okugawa et al., 2007) Similarly, earlier age of first cannabis use has been linked to decreased FA and increased RD in long-range tracts.(Orr et al., 2016) Thus, some of the white matter abnormalities observed in this study may be related to above factors, requiring larger studies to investigate. However, the absence of substantial findings in those with bipolar disorder, which has among the highest rates of substance use may partly argue against a major role in our findings,(Ringen et al., 2008) patterns of substance use tend to differ between disorders, with schizophrenia subjects more likely using non-alcoholic drugs.(Ringen et al., 2008) Secondly, while DBSI has been validated in preclinical models of white matter injury(Lin et al., 2019) and in autopsied multiple sclerosis brain specimens,(George et al., 2017) these results may not be completely valid in schizophrenia patients. A validation study involving postmortem schizophrenia samples is currently ongoing by our group. Thirdly, while the characteristic DBSI findings reported were observed in the majority of schizophrenia participants, they were not present in several participants, consistent with the heterogeneous brain profiles of the disorder.(Arnedo et al., 2015) Larger sample sizes and longitudinal investigations would provide deeper insight into distinct schizophrenia biotypes, and brain changes at varying time points across the life span.

Our study shows that a novel diffusion imaging method, DBSI, could be used to safely identify unique microstructural changes in the brain, and has potential for clinical application in the future, including personalizing therapies. Specific white matter structural abnormalities, such as decreased neurite density, likely relate to poorer long-term prognosis and response to specific medications,(Rae et al., 2017) and can therefore aid in the treatment selection. DBSI metrics could be used to monitor treatment effects, and may also identify individuals most at risk for developing psychosis who would benefit from preventative interventions before the onset of psychosis.

Ethical Approval

The work described has been carried out in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki) and received ethical approval from the Institutional Review Board of Washington University in St. Louis, Missouri, USA.

Competing interests

There are no financial or personal conflicts for any of the authors regarding this work.

Authors' contributions

D.M. and A.P. wrote the main manuscript text, conducted analyses, and prepared figures. A.P. and S.C. processed and analyzed neuroimaging data. Q.W. oversaw image acquisition and processing. Y.W. and Q.W. oversaw data analyses and interpreted results. All authors reviewed the manuscript

Funding

This work was supported by the National Institute of Mental Health (Grant No. R01MH104414 [to DM]; and Grant No. R21MH131962 [to DM and YW]).

Availability of data and materials

Data will be available upon request to the corresponding author.

Alba-Ferrara, L. M., & de Erausquin, G. A. (2013). What does anisotropy measure? Insights from increased and decreased anisotropy in selective fiber tracts in schizophrenia. Frontiers in Integrative Neuroscience, 7. https://doi.org/10.3389/fnint.2013.00009
Andersson, J. L. R., Graham, M. S., Drobnjak, I., Zhang, H., & Campbell, J. (2018). Susceptibility-induced distortion that varies due to motion: Correction in diffusion MR without acquiring additional data. NeuroImage, 171, 277–295. https://doi.org/10.1016/j.neuroimage.2017.12.040
Andersson, J. L. R., Graham, M. S., Drobnjak, I., Zhang, H., Filippini, N., & Bastiani, M. (2017). Towards a comprehensive framework for movement and distortion correction of diffusion MR images: Within volume movement. NeuroImage, 152, 450–466. https://doi.org/10.1016/j.neuroimage.2017.02.085
Andersson, J. L. R., Graham, M. S., Zsoldos, E., & Sotiropoulos, S. N. (2016). Incorporating outlier detection and replacement into a non-parametric framework for movement and distortion correction of diffusion MR images. NeuroImage, 141, 556–572. https://doi.org/10.1016/j.neuroimage.2016.06.058
Andersson, J. L. R., Skare, S., & Ashburner, J. (2003). How to correct susceptibility distortions in spin-echo echo-planar images: application to diffusion tensor imaging. NeuroImage, 20(2), 870–888. https://doi.org/10.1016/S1053-8119(03)00336-7
Andersson, J. L. R., & Sotiropoulos, S. N. (2016). An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging. NeuroImage, 125, 1063–1078. https://doi.org/10.1016/j.neuroimage.2015.10.019
Andreasen, N. C. (1990). Methods for assessing positive and negative symptoms. Modern Problems of Pharmacopsychiatry, 24, 73–88. https://doi.org/10.1159/000418013
Arnedo, J., Mamah, D., Baranger, D. A., Harms, M. P., Barch, D. M., Svrakic, D. M., de Erausquin, G. A., Cloninger, C. R., & Zwir, I. (2015). Decomposition of brain diffusion imaging data uncovers latent schizophrenias with distinct patterns of white matter anisotropy. NeuroImage, 120, 43–54. https://doi.org/10.1016/j.neuroimage.2015.06.083
Baijot, J., Van Laethem, D., Denissen, S., Costers, L., Cambron, M., D’Haeseleer, M., D’hooghe, M. B., Vanbinst, A.-M., De Mey, J., Nagels, G., & Van Schependom, J. (2022). Radial diffusivity reflects general decline rather than specific cognitive deterioration in multiple sclerosis. Scientific Reports, 12(1), 21771. https://doi.org/10.1038/s41598-022-26204-z
Bishop, J. R., Zhang, L., & Lizano, P. (2022). Inflammation Subtypes and Translating Inflammation-Related Genetic Findings in Schizophrenia and Related Psychoses: A Perspective on Pathways for Treatment Stratification and Novel Therapies. Harvard Review of Psychiatry, 30(1), 59–70. https://doi.org/10.1097/HRP.0000000000000321
Black, J. E., Kodish, I. M., Grossman, A. W., Klintsova, A. Y., Orlovskaya, D., Vostrikov, V., Uranova, N., & Greenough, W. T. (2004). Pathology of Layer V Pyramidal Neurons in the Prefrontal Cortex of Patients With Schizophrenia. American Journal of Psychiatry, 161(4), 742–744. https://doi.org/10.1176/appi.ajp.161.4.742
Brown, A. S., & Derkits, E. J. (2010). Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies. American Journal of Psychiatry, 167(3), 261–280. https://doi.org/10.1176/appi.ajp.2009.09030361
BYNE, W., KIDKARDNEE, S., TATUSOV, A., YIANNOULOS, G., BUCHSBAUM, M., & HAROUTUNIAN, V. (2006). Schizophrenia-associated reduction of neuronal and oligodendrocyte numbers in the anterior principal thalamic nucleus. Schizophrenia Research, 85(1–3), 245–253. https://doi.org/10.1016/j.schres.2006.03.029
Cai, H. Q., Catts, V. S., Webster, M. J., Galletly, C., Liu, D., O’Donnell, M., Weickert, T. W., & Weickert, C. S. (2020). Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation. Molecular Psychiatry, 25(4), 761–775. https://doi.org/10.1038/s41380-018-0235-x
Chiang, C.-W., Wang, Y., Sun, P., Lin, T.-H., Trinkaus, K., Cross, A. H., & Song, S.-K. (2014). Quantifying white matter tract diffusion parameters in the presence of increased extra-fiber cellularity and vasogenic edema. NeuroImage, 101, 310–319. https://doi.org/10.1016/j.neuroimage.2014.06.064
Corsi-Zuelli, F., & Deakin, B. (2021). Impaired regulatory T cell control of astroglial overdrive and microglial pruning in schizophrenia. Neuroscience & Biobehavioral Reviews, 125, 637–653. https://doi.org/10.1016/j.neubiorev.2021.03.004
Cross, A. H., & Song, S.-K. (2017). “A new imaging modality to non-invasively assess multiple sclerosis pathology.” Journal of Neuroimmunology, 304, 81–85. https://doi.org/10.1016/j.jneuroim.2016.10.002
Duchatel, R. J., Shannon Weickert, C., & Tooney, P. A. (2019). White matter neuron biology and neuropathology in schizophrenia. Npj Schizophrenia, 5(1), 10. https://doi.org/10.1038/s41537-019-0078-8
Fillman, S. G., Sinclair, D., Fung, S. J., Webster, M. J., & Shannon Weickert, C. (2014). Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder. Translational Psychiatry, 4(2), e365–e365. https://doi.org/10.1038/tp.2014.8
First, M., Spitzer, R., Gibbon, M., & Williams, B. (1996). Structured clinical interview for DSM-IV axis I disorders, clinical version (SCID-CV).
George, A., Sun, P., Cross, A. H., Wang, X., Perez-Torres, C., & Song, S.-K. (2017). Histological validation of diffusion basis spectrum imaging using autopsied multiple sclerosis brain specimen. International Society for Magnetic Resonance in Medicine. https://cds.ismrm.org/protected/17MProceedings/PDFfiles/2557.html
Glasser, M. F., Smith, S. M., Marcus, D. S., Andersson, J. L. R., Auerbach, E. J., Behrens, T. E. J., Coalson, T. S., Harms, M. P., Jenkinson, M., Moeller, S., Robinson, E. C., Sotiropoulos, S. N., Xu, J., Yacoub, E., Ugurbil, K., & Van Essen, D. C. (2016). The Human Connectome Project’s neuroimaging approach. Nature Neuroscience, 19(9), 1175–1187. https://doi.org/10.1038/nn.4361
Glasser, M. F., Sotiropoulos, S. N., Wilson, J. A., Coalson, T. S., Fischl, B., Andersson, J. L., Xu, J., Jbabdi, S., Webster, M., Polimeni, J. R., Van Essen, D. C., & Jenkinson, M. (2013). The minimal preprocessing pipelines for the Human Connectome Project. NeuroImage, 80, 105–124. https://doi.org/10.1016/j.neuroimage.2013.04.127
Godwin, D., Alpert, K. I., Wang, L., & Mamah, D. (2018). Regional cortical thinning in young adults with schizophrenia but not psychotic or non-psychotic bipolar I disorder. International Journal of Bipolar Disorders, 6(1), 16. https://doi.org/10.1186/s40345-018-0124-x
Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016). A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Molecular Psychiatry, 21(12), 1696–1709. https://doi.org/10.1038/mp.2016.3
Howes, O. D., & McCutcheon, R. (2017). Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization. Translational Psychiatry, 7(2), e1024–e1024. https://doi.org/10.1038/tp.2016.278
Jaaro-Peled, H., Ayhan, Y., Pletnikov, M. V., & Sawa, A. (2010). Review of Pathological Hallmarks of Schizophrenia: Comparison of Genetic Models With Patients and Nongenetic Models. Schizophrenia Bulletin, 36(2), 301–313. https://doi.org/10.1093/schbul/sbp133
Kelly, S., Jahanshad, N., Zalesky, A., Kochunov, P., Agartz, I., Alloza, C., Andreassen, O. A., Arango, C., Banaj, N., Bouix, S., Bousman, C. A., Brouwer, R. M., Bruggemann, J., Bustillo, J., Cahn, W., Calhoun, V., Cannon, D., Carr, V., Catts, S., … Donohoe, G. (2018). Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group. Molecular Psychiatry, 23(5), 1261–1269. https://doi.org/10.1038/mp.2017.170
Khoury, R., & Nasrallah, H. A. (2018). Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait? Schizophrenia Research, 199, 31–38. https://doi.org/10.1016/j.schres.2018.04.017
Kubicki, M., McCarley, R. W., & Shenton, M. E. (2005). Evidence for white matter abnormalities in schizophrenia. Current Opinion in Psychiatry, 18(2), 121–134. https://doi.org/10.1097/00001504-200503000-00004
Levitt, J. J., Alvarado, J. L., Nestor, P. G., Rosow, L., Pelavin, P. E., McCarley, R. W., Kubicki, M., & Shenton, M. E. (2012). Fractional anisotropy and radial diffusivity: Diffusion measures of white matter abnormalities in the anterior limb of the internal capsule in schizophrenia. Schizophrenia Research, 136(1–3), 55–62. https://doi.org/10.1016/J.SCHRES.2011.09.009
Lin, T.-H., Sun, P., Hallman, M., Hwang, F. C., Wallendorf, M., Ray, W. Z., Spees, W. M., & Song, S.-K. (2019). Noninvasive Quantification of Axonal Loss in the Presence of Tissue Swelling in Traumatic Spinal Cord Injury Mice. Journal of Neurotrauma, 36(15), 2308–2315. https://doi.org/10.1089/neu.2018.6016
Mamah, D., Chen, S., Shimony, J. S., & Harms, M. P. (2024). Tract-based analyses of white matter in schizophrenia, bipolar disorder, aging, and dementia using high spatial and directional resolution diffusion imaging: a pilot study. Frontiers in Psychiatry, 15. https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1240502
Mamah, D., Conturo, T. E., Harms, M. P., Akbudak, E., Wang, L., McMichael, A. R., Gado, M. H., Barch, D. M., & Csernansky, J. G. (2010). Anterior thalamic radiation integrity in schizophrenia: A diffusion-tensor imaging study. Psychiatry Research: Neuroimaging, 183(2), 144–150. https://doi.org/10.1016/j.pscychresns.2010.04.013
Mamah, D., Ji, A., Rutlin, J., & Shimony, J. S. (2019). White matter integrity in schizophrenia and bipolar disorder: Tract- and voxel-based analyses of diffusion data from the Connectom scanner. NeuroImage: Clinical, 21, 101649. https://doi.org/10.1016/j.nicl.2018.101649
Mamah, D., Mutiso, V. N., & Ndetei, D. M. (2021). Psychotic-like experiences among 9,564 Kenyan adolescents and young adults. Psychiatry Research, 302, 113994. https://doi.org/10.1016/j.psychres.2021.113994
Mamah, D., Mutiso, V. N., & Ndetei, D. M. (2022). Longitudinal and cross-sectional validation of the WERCAP screen for assessing psychosis risk and conversion. Schizophrenia Research, 241, 201–209. https://doi.org/10.1016/j.schres.2022.01.031
Mamah, D., Owoso, A., Sheffield, J. M., & Bayer, C. (2014). The WERCAP Screen and the WERC Stress Screen: psychometrics of self-rated instruments for assessing bipolar and psychotic disorder risk and perceived stress burden. Comprehensive Psychiatry, 55(7), 1757–1771. https://doi.org/10.1016/j.comppsych.2014.07.004
Marques, T. R., Ashok, A. H., Pillinger, T., Veronese, M., Turkheimer, F. E., Dazzan, P., Sommer, I. E. C., & Howes, O. D. (2019). Neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies. Psychological Medicine, 49(13), 2186–2196. https://doi.org/10.1017/S0033291718003057
Mugler, J. P., Bao, S., Mulkern, R. V., Guttmann, C. R. G., Robertson, R. L., Jolesz, F. A., & Brookeman, J. R. (2000). Optimized Single-Slab Three-dimensional Spin-Echo MR Imaging of the Brain. Radiology, 216(3), 891–899. https://doi.org/10.1148/radiology.216.3.r00au46891
Mugler, J. P., & Brookeman, J. R. (1990). Three‐dimensional magnetization‐prepared rapid gradient‐echo imaging (3D MP RAGE). Magnetic Resonance in Medicine, 15(1), 152–157. https://doi.org/10.1002/mrm.1910150117
Narayanaswami, V., Dahl, K., Bernard-Gauthier, V., Josephson, L., Cumming, P., & Vasdev, N. (2018). Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO. Molecular Imaging, 17, 153601211879231. https://doi.org/10.1177/1536012118792317
Nortje, G., Stein, D. J., Radua, J., Mataix-Cols, D., & Horn, N. (2013). Systematic review and voxel-based meta-analysis of diffusion tensor imaging studies in bipolar disorder. Journal of Affective Disorders, 150(2), 192–200. https://doi.org/10.1016/j.jad.2013.05.034
Okugawa, G., Nobuhara, K., Takase, K., Saito, Y., Yoshimura, M., & Kinoshita, T. (2007). Olanzapine Increases Grey and White Matter Volumes in the Caudate Nucleus of Patients with Schizophrenia. Neuropsychobiology, 55(1), 43–46. https://doi.org/10.1159/000103575
Orr, J. M., Paschall, C. J., & Banich, M. T. (2016). Recreational marijuana use impacts white matter integrity and subcortical (but not cortical) morphometry. NeuroImage: Clinical, 12, 47–56. https://doi.org/10.1016/j.nicl.2016.06.006
Quarantelli, M. (2015). MRI/MRS in neuroinflammation: methodology and applications. Clinical and Translational Imaging, 3(6), 475–489. https://doi.org/10.1007/s40336-015-0142-y
Rae, C. L., Davies, G., Garfinkel, S. N., Gabel, M. C., Dowell, N. G., Cercignani, M., Seth, A. K., Greenwood, K. E., Medford, N., & Critchley, H. D. (2017). Deficits in Neurite Density Underlie White Matter Structure Abnormalities in First-Episode Psychosis. Biological Psychiatry, 82(10), 716–725. https://doi.org/10.1016/j.biopsych.2017.02.008
Ringen, P. A., Lagerberg, T. V., Birkenæs, A. B., Engn, J., Færden, A., Jónsdottir, H., Nesvåg, R., Friis, S., Opjordsmoen, S., Larsen, F., Melle, I., & Andreassen, O. A. (2008). Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder. Psychological Medicine, 38(9), 1241–1249. https://doi.org/10.1017/S003329170700236X
Roussos, P., & Haroutunian, V. (2014). Schizophrenia: susceptibility genes and oligodendroglial and myelin related abnormalities. Frontiers in Cellular Neuroscience, 8. https://doi.org/10.3389/fncel.2014.00005
Ruzzo, E. K., & Geschwind, D. H. (2016). Schizophrenia genetics complements its mechanistic understanding. Nature Neuroscience, 19(4), 523–525. https://doi.org/10.1038/nn.4277
Samara, A., Murphy, T., Strain, J., Rutlin, J., Sun, P., Neyman, O., Sreevalsan, N., Shimony, J. S., Ances, B. M., Song, S.-K., Hershey, T., & Eisenstein, S. A. (2020). Neuroinflammation and White Matter Alterations in Obesity Assessed by Diffusion Basis Spectrum Imaging. Frontiers in Human Neuroscience, 13. https://doi.org/10.3389/fnhum.2019.00464
Smith, S. M., Jenkinson, M., Johansen-Berg, H., Rueckert, D., Nichols, T. E., Mackay, C. E., Watkins, K. E., Ciccarelli, O., Cader, M. Z., Matthews, P. M., & Behrens, T. E. J. (2006). Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. NeuroImage, 31(4), 1487–1505. https://doi.org/10.1016/j.neuroimage.2006.02.024
Sotiropoulos, S. N., Jbabdi, S., Xu, J., Andersson, J. L., Moeller, S., Auerbach, E. J., Glasser, M. F., Hernandez, M., Sapiro, G., Jenkinson, M., Feinberg, D. A., Yacoub, E., Lenglet, C., Van Essen, D. C., Ugurbil, K., & Behrens, T. E. J. (2013). Advances in diffusion MRI acquisition and processing in the Human Connectome Project. NeuroImage, 80, 125–143. https://doi.org/10.1016/j.neuroimage.2013.05.057
Strain, J. F., Burdo, T. H., Song, S.-K., Sun, P., El-Ghazzawy, O., Nelson, B., Westerhaus, E., Baker, L., Vaida, F., & Ances, B. M. (2017). Diffusion Basis Spectral Imaging Detects Ongoing Brain Inflammation in Virologically Well-Controlled HIV+ Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes, 76(4), 423–430. https://doi.org/10.1097/QAI.0000000000001513
Tkachev, D., Mimmack, M. L., Ryan, M. M., Wayland, M., Freeman, T., Jones, P. B., Starkey, M., Webster, M. J., Yolken, R. H., & Bahn, S. (2003). Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. The Lancet, 362(9386), 798–805. https://doi.org/10.1016/S0140-6736(03)14289-4
Vostrikov, V. M., & Uranova, N. A. (2020). Reduced density of oligodendrocytes and oligodendrocyte clusters in the caudate nucleus in major psychiatric illnesses. Schizophrenia Research, 215, 211–216. https://doi.org/10.1016/j.schres.2019.10.027
Wang, Q., Cheung, C., Deng, W., Li, M., Huang, C., Ma, X., Wang, Y., Jiang, L., Sham, P. C., Collier, D. A., Gong, Q., Chua, S. E., McAlonan, G. M., & Li, T. (2013). White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment. Psychological Medicine, 43(11), 2301–2309. https://doi.org/10.1017/S0033291713000238
Wang, Q., Wang, Y., Liu, J., Sutphen, C. L., Cruchaga, C., Blazey, T., Gordon, B. A., Su, Y., Chen, C., Shimony, J. S., Ances, B. M., Cairns, N. J., Fagan, A. M., Morris, J. C., & Benzinger, T. L. S. (2019). Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer’s disease. NeuroImage: Clinical, 22, 101767. https://doi.org/10.1016/j.nicl.2019.101767
Wang, X., Cusick, M. F., Wang, Y., Sun, P., Libbey, J. E., Trinkaus, K., Fujinami, R. S., & Song, S. (2014). Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice. NMR in Biomedicine, 27(7), 843–852. https://doi.org/10.1002/nbm.3129
Wang, Y., Sun, P., Wang, Q., Trinkaus, K., Schmidt, R. E., Naismith, R. T., Cross, A. H., & Song, S.-K. (2015). Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis. Brain, 138(5), 1223–1238. https://doi.org/10.1093/brain/awv046
Wang, Y., Wang, Q., Haldar, J. P., Yeh, F.-C., Xie, M., Sun, P., Tu, T.-W., Trinkaus, K., Klein, R. S., Cross, A. H., & Song, S.-K. (2011). Quantification of increased cellularity during inflammatory demyelination. Brain, 134(12), 3590–3601. https://doi.org/10.1093/brain/awr307
Winkler, A. M., Ridgway, G. R., Webster, M. A., Smith, S. M., & Nichols, T. E. (2014). Permutation inference for the general linear model. NeuroImage, 92, 381–397. https://doi.org/https://doi.org/10.1016/j.neuroimage.2014.01.060
Wu, W., Wang, Q., Sun, Z., Flores, S., Hobbs, D. A., Franklin, E. E., Perrin, R. J., Benzinger, T. L. S., & Wang, Y. (2022). Initial Correlation Analysis of Diffusion Basis Spectrum Imaging of Alzheimer’s Brain and Quantitative Histology. Alzheimer’s & Dementia, 18(S6). https://doi.org/10.1002/alz.064265
Yang, Y., Fung, S. J., Rothwell, A., Tianmei, S., & Weickert, C. S. (2011). Increased Interstitial White Matter Neuron Density in the Dorsolateral Prefrontal Cortex of People with Schizophrenia. Biological Psychiatry, 69(1), 63–70. https://doi.org/10.1016/j.biopsych.2010.08.020
Zhang, J. K., Sun, P., Jayasekera, D., Greenberg, J. K., Javeed, S., Dibble, C. F., Blum, J., Song, C., Song, S.-K., & Ray, W. Z. (2022). Utility of Diffusion Basis Spectrum Imaging in Quantifying Baseline Disease Severity and Prognosis of Cervical Spondylotic Myelopathy. Spine, 47(24), 1687–1693. https://doi.org/10.1097/BRS.0000000000004456

Tables 1 and 2 are available in the Supplementary Files section.

No competing interests reported.

TablesDBSIPR2024BIB.pdf

Download PDF

Reviews received at journal
20 Nov, 2024
Reviewers agreed at journal
12 Nov, 2024
Reviewers agreed at journal
10 Nov, 2024
Reviewers agreed at journal
08 Nov, 2024
Reviews received at journal
19 Sep, 2024
Reviewers agreed at journal
08 Sep, 2024
Reviewers invited by journal
03 Sep, 2024
Editor assigned by journal
03 Sep, 2024
Submission checks completed at journal
19 Aug, 2024
First submitted to journal
19 Aug, 2024

You are reading this latest preprint version

Diffusion Basis Spectrum Imaging of White Matter in Schizophrenia and Bipolar Disorder

Status:

Version 1

Abstract

Figures

Introduction

Methods

Subjects

Behavioral assessments

Image acquisition

Image preprocessing

DBSI

Statistical analysis

Results

Demographic and clinical profiles:

Voxel-wise analysis of DTI-derived fractional anisotropy, radial diffusivity, and axial diffusivity

Voxel-wise analysis of cellular diffusion fraction

Voxel-wise analysis of axonal fiber fraction

Voxel-wise analysis of extra-axonal water fraction

Voxel-wise analysis of DBSI-derived fiber axial and fiber radial diffusivity

Correlation analysis between WERCAP symptom score and DBSI measures

Discussion

Declarations

References

Tables

Additional Declarations

Supplementary Files

Status:

Version 1